Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome (2009)
- Authors:
- USP affiliated authors: GERLACH, RAQUEL FERNANDA - FORP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidades: FORP; FMRP
- DOI: 10.1016/j.cca.2009.02.013
- Subjects: DOENÇAS METABÓLICAS; METALOPROTEINASES
- Language: Inglês
- Imprenta:
- Source:
- Título: Clinica Chimica Acta
- ISSN: 0009-8981
- Volume/Número/Paginação/Ano: v. 403, n. 1-2, p. 173-177, 2009
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
GONÇALVES, Flávia Munhoso et al. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome. Clinica Chimica Acta, v. 403, n. 1-2, p. 173-177, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2009.02.013. Acesso em: 10 fev. 2026. -
APA
Gonçalves, F. M., Ferreira, A. L. B. J., Gomes, V. A., Casella Filho, A., Chagas, A. C. P., Marcaccini, A. M., et al. (2009). Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome. Clinica Chimica Acta, 403( 1-2), 173-177. doi:10.1016/j.cca.2009.02.013 -
NLM
Gonçalves FM, Ferreira ALBJ, Gomes VA, Casella Filho A, Chagas ACP, Marcaccini AM, Gerlach RF, Santos JET dos. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome [Internet]. Clinica Chimica Acta. 2009 ; 403( 1-2): 173-177.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1016/j.cca.2009.02.013 -
Vancouver
Gonçalves FM, Ferreira ALBJ, Gomes VA, Casella Filho A, Chagas ACP, Marcaccini AM, Gerlach RF, Santos JET dos. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome [Internet]. Clinica Chimica Acta. 2009 ; 403( 1-2): 173-177.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1016/j.cca.2009.02.013 - Recombinant human matrix metalloproteinase-2 impairs cardiovascular 'beta'-adrenergic responses
- Circulating cell-free DNA levels in plasma increase with severity in experimental acute pulmonary thromboembolism
- The effect of sildenafil on pulmonary embolism-induced oxidative stress and pulmonary hypertension
- Sodium nitrite attenuates MMP-9 production by endothelial cells and may explain similar effects of atorvastatin
- Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension
- Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension
- Nitrite or sildenafil, but not BAY 41-2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress
- Chronic treatment with nebivolol attenuates the vascular changes in the 2-kidney, 1-clip model of renovascular hypertension
- Circulating matrix metalloproteinases and their inhibitors in hypertension
- Metalloproteinase inhibition protects against cardiomyocyte injury during experimental acute pulmonary thromboembolism
Informações sobre o DOI: 10.1016/j.cca.2009.02.013 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
